GROWTH HORMONE DEFICIENCY IN ADULTS WITH THALASSEMIA: AN OVERVIEW AND THE I-CET RECOMMENDATIONS

01 settembre 2013

Soliman A, De Sanctis V, Elsedfy H, Yassin M, Skordis N, Karimi M, Sobti P, Raiola G, El Kholy M.

Department of Pediatrics, Division of Endocrinology, Hamad General Hospital Doha, Qatar; Pediatric, Endocrinology and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy; Department of Pediatrics, Ain Shams University, Cairo, Egypt; Department of Paediatrics, Division of Pediatric Endocrinology, Makarios Hospital, Nicosia, Cyprus; Department of Hematology, Alamal Hospital, Hamad Medical Center, Doha, Qatar; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pediatrics, Dayanand Medical College, Ludhiana, Punjab, India; Department of Pediatrics, Pugliese-Ciaccio Hospital, Catanzaro, Italy.

Abstract

This review paper provides a summary of the current state of knowledge regarding GHD provides recommendations for the diagnosis and treatment of GHD in adult patients with thalassaemia major (TM). The reported prevalence of adult GHD and /or IGF-I deficiency in TM patients varies from 8% to 44 % in different centers. Because GH treatment requires analysis of many factors, including the effect of treatment on cardiac functions, metabolic parameters and psychosocial functioning, along with safety, ethical considerations, financial cost and other burdens of therapy, stringent diagnostic criteria are needed.

The authors report the diagnostic recommendations of the International Study Group of Endocrine Complications in Thalassemia (I-CET) for adult TM patients. The pros and cons of GH treatment must be discussed with each patient, after which GH doses should be individualized and titrated to maximum efficacy with minimal side effects.

Prospective studies to monitor potential benefits versus possible side-effects will enable endocrinologists to define recommendations on dosage and the long term effects, particularly on cardiovascular and bone status of GH therapy in adult TM patients.

Pub Med

Source: http://www.ncbi.nlm.nih.gov/pubmed/24099819

GROWTH HORMONE DEFICIENCY IN ADULTS WITH THALASSEMIA: AN OVERVIEW AND THE I-CET RECOMMENDATIONS

Categorie

Ultimi post

Quisisana a sostegno del Premio ...

Quisisana è lieta di sostenere il ...

Reparto di reumatologia: benvenuto ...

Reparto di Neurologia: benvenuta ...

Altri post della stessa categoria

Relationship between emotional bradycardia in animals and vasovagal syncope in humans. Physiol Behav

Neurally mediated syncope starting in old age does not appear to be unique to humans: new perspective

Emorragia gastrointestinale maggiore in corso di terapia anticoagulante nei pazienti con fibrillazione atriale: quando riprendere il trattamento?

Initial Clinical Evaluation

Il trattamento anticoagulante nei pazienti con fibrillazione atriale non valvolare e anemia cronica: ancora zone grigie

Quisisana: pubblicato sul Journal of Cardiovascular Medicine l'intervento del Dottor Alboni

I "Giovedì della salute" negli spazi del Poliambulatorio Quisisana di Ferrara

Il Dottor Stefano Romagnoli interviene su sarcopenia e il microbiota.

IL PROGETTO EQUALITY

TERAPIA DELLA SINCOPE SENOCAROTIDEA

IL SESTO MAGAZINE DEL PROGETTO EQUALITY

IL QUINTO MAGAZINE DEL PROGETTO EQUALITY

Prenota la tua visita online